Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy G Yandle

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|August 14, 2003
Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failureJeffrey W H Fung, Cheuk M Yu, Gabriel Yip, et al.
Endocrinology|May 19, 2007
C-type natriuretic peptide forms in the ovine fetal and maternal circulations: evidence for independent regulation and reciprocal response to undernutritionTimothy C R Prickett, Christopher W H Rumball, Alex J Buckley, et al.
European Heart Journal|August 28, 2007
Urocortin 2 infusion in human heart failureMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
Clinical Science (London, England : 1979)|May 11, 2005
Effect of urocortin 1 infusion in humans with stable congestive cardiac failureMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Urocortin-1 infusion in normal humansMark E Davis, Chris J Pemberton, Timothy G Yandle, et al.
Journal of the American College of Cardiology|January 30, 2007
Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responsesMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
Pediatric Research|July 12, 2005
Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growthTimothy C R Prickett, Adrienne M Lynn, Graham K Barrell, et al.
Clinical Chemistry|May 17, 2019
ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart FailureLynley K Lewis, Sara D Raudsepp, Timothy C R Prickett, et al.
Journal of the American College of Cardiology|February 2, 2010
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trialJohn G Lainchbury, Richard W Troughton, Kim M Strangman, et al.
Journal of Cardiac Failure|July 31, 2010
Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failureW H Wilson Tang, Kevin Shrestha, Maureen G Martin, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|August 14, 2003
Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failureJeffrey W H Fung, Cheuk M Yu, Gabriel Yip, et al.
Endocrinology|May 19, 2007
C-type natriuretic peptide forms in the ovine fetal and maternal circulations: evidence for independent regulation and reciprocal response to undernutritionTimothy C R Prickett, Christopher W H Rumball, Alex J Buckley, et al.
European Heart Journal|August 28, 2007
Urocortin 2 infusion in human heart failureMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
Clinical Science (London, England : 1979)|May 11, 2005
Effect of urocortin 1 infusion in humans with stable congestive cardiac failureMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Urocortin-1 infusion in normal humansMark E Davis, Chris J Pemberton, Timothy G Yandle, et al.
Journal of the American College of Cardiology|January 30, 2007
Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responsesMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
Pediatric Research|July 12, 2005
Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growthTimothy C R Prickett, Adrienne M Lynn, Graham K Barrell, et al.
Clinical Chemistry|May 17, 2019
ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart FailureLynley K Lewis, Sara D Raudsepp, Timothy C R Prickett, et al.
Journal of the American College of Cardiology|February 2, 2010
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trialJohn G Lainchbury, Richard W Troughton, Kim M Strangman, et al.
Journal of Cardiac Failure|July 31, 2010
Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failureW H Wilson Tang, Kevin Shrestha, Maureen G Martin, et al.
Pageof 6